DS
ENZY

David Shaw’s Enzymotec Ltd ENZY Stock Holding History

David Shaw’s Portfolio ENZY Stock Details ENZY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q1 		– Sell
-35,669
Closed -$268K – 4209
2014
Q4 		$268K Sell
35,669
-250,982
-88% -$1.82M ﹤0.01% 3699
2014
Q3 		$1.92M Sell
286,651
-44,923
-14% -$485K ﹤0.01% 2282
2014
Q2 		$4.5M Buy
331,574
+303,698
+1,089% +$5.1M 0.01% 1699
2014
Q1 		$614K Buy
+27,876
New +$739K ﹤0.01% 3425

Other funds holding ENZY

PC
Paulson & Co New York $2.58B AUM 68.51% 1-Year Est. Return
VAM
Visium Asset Management New York $1.43B AUM 3.58% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
California Public Employees Retirement System
California Public Employees Retirement System Sacramento, California $177B AUM 39.86% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
AP
Alydar Partners Boston, Massachusetts $185M AUM 42.33% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return

David Shaw's ENZY Position: Q1 2015 in Review

David Shaw sold out of Enzymotec Ltd (ENZY) in Q1 2015, closing a stake of 35,669 shares — an estimated $268K sold.

David Shaw first reported a position in ENZY in Q1 2014 and held it in 4 quarters. The position peaked at $4.5M in Q2 2014. 20 funds tracked by Wall St. Rank hold ENZY as of Q1 2015.

  • David Shaw reported no remaining Enzymotec Ltd position as of Q1 2015 after selling out during the quarter.
  • David Shaw sold 35,669 Enzymotec Ltd shares in Q1 2015, an estimated $268K.
  • David Shaw first reported a position in Enzymotec Ltd in Q1 2014 and held it in 4 quarters.
  • David Shaw's Enzymotec Ltd position peaked at $4.5M in Q2 2014.
  • 20 funds tracked by Wall St. Rank held Enzymotec Ltd as of Q1 2015.

Based on D.E. Shaw & Co's 13F filing for Q1 2015, filed 15 May 2015.